The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Recent Developments in the Crystallization Process: Toward the Pharmaceutical Industry
Open accessAbstract
Crystallization is one of the oldest separation and purification unit operations, and has recently contributed to significant improvements in producing higher-value products with specific properties and in building efficient manufacturing processes. In this paper, we review recent developments in crystal engineering and crystallization process design and control in the pharmaceutical industry. We systematically summarize recent methods for understanding and developing new types of crystals such as co-crystals, polymorphs, and solvates, and include several milestones such as the launch of the first co-crystal drug, Entresto (Novartis), and the continuous manufacture of Orkambi (Vertex). Conventional batch and continuous processes, which are becoming increasingly mature, are being coupled with various control strategies and the recently developed crystallizers are thus adapting to the needs of the pharmaceutical industry. The development of crystallization process design and control has led to the appearance of several new and innovative crystallizer geometries for continuous operation and improved performance. This paper also reviews major recent progress in the area of process analytical technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Photodimerization in the solid state
Schmidt, G. M. J. (1971) · Pure and Applied Chemistry · doi:10.1351/pac197127040647 · Cited by 2,095
Crystal Engineering: A Holistic View
Desiraju, G. R. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700534 · Cited by 1,499
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Adamo, A., Beingessner, R. L., Behnam, M., Chen, J., Jamison, T. F., Jensen, K. F., Monbaliu, J.-C. M., Myerson, A. S., Revalor, E. M., Snead, D. R., et al. (2016) · Science · doi:10.1126/science.aaf1337 · Cited by 941
Pharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
Lindenberg, M., Kopp, S., & Dressman, J. B. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.001 · Cited by 864
Mascia, S., Heider, P. L., Zhang, H., Lakerveld, R., Benyahia, B., Barton, P. I., Braatz, R. D., Cooney, C. L., Evans, J. M. B., Jamison, T. F., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305429 · Cited by 599
Report on the sixth blind test of organic crystal structure prediction methods
Reilly, A. M., Cooper, R. I., Adjiman, C. S., Bhattacharya, S., Boese, A. D., Brandenburg, J. G., Bygrave, P. J., Bylsma, R., Campbell, J. E., Car, R., et al. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616007447 · Cited by 584
Microscopic Evidence for Liquid-Liquid Separation in Supersaturated CaCO 3 Solutions
Wallace, A. F., Hedges, L. O., Fernandez-Martinez, A., Raiteri, P., Gale, J. D., Waychunas, G. A., Whitelam, S., Banfield, J. F., & De Yoreo, J. J. (2013) · Science · doi:10.1126/science.1230915 · Cited by 515
Microwave and ultrasonic processing: Now a realistic option for industry
Leonelli, C., & Mason, T. J. (2010) · Chemical Engineering and Processing: Process Intensification · doi:10.1016/j.cep.2010.05.006 · Cited by 512
Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review
Simon, L. L., Pataki, H., Marosi, G., Meemken, F., Hungerbühler, K., Baiker, A., Tummala, S., Glennon, B., Kuentz, M., Steele, G., et al. (2015) · Organic Process Research & Development · doi:10.1021/op500261y · Cited by 439
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
The role of co-crystals in pharmaceutical design
Steed, J. W. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.12.003 · Cited by 341
Advances and New Directions in Crystallization Control
Nagy, Z. K., & Braatz, R. D. (2012) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-062011-081043 · Cited by 332
Recent advances in the monitoring, modelling and control of crystallization systems
Nagy, Z. K., Fevotte, G., Kramer, H., & Simon, L. L. (2013) · Chemical Engineering Research and Design · doi:10.1016/j.cherd.2013.07.018 · Cited by 297
Aakeröy, C. B., Forbes, S., & Desper, J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907674c · Cited by 297
Eutectics as improved pharmaceutical materials: design, properties and characterization
Cherukuvada, S., & Nangia, A. (2014) · Chem. Commun. · doi:10.1039/c3cc47521b · Cited by 296
Abu Bakar, M. R., Nagy, Z. K., Saleemi, A. N., & Rielly, C. D. (2009) · Crystal Growth & Design · doi:10.1021/cg800595v · Cited by 258
Oscillatory Flow Reactors (OFRs) for Continuous Manufacturing and Crystallization
McGlone, T., Briggs, N. E. B., Clark, C. A., Brown, C. J., Sefcik, J., & Florence, A. J. (2015) · Organic Process Research & Development · doi:10.1021/acs.oprd.5b00225 · Cited by 222
Myerson, A. S., & Trout, B. L. (2013) · Science · doi:10.1126/science.1243022 · Cited by 213
Diao, Y., Myerson, A. S., Hatton, T. A., & Trout, B. L. (2011) · Langmuir · doi:10.1021/la104351k · Cited by 209
Vaterite growth and dissolution in aqueous solution III. Kinetics of transformation
Kralj, D., Brečević, L., & Kontrec, J. (1997) · Journal of Crystal Growth · doi:10.1016/s0022-0248(96)01128-1 · Cited by 202
Model based robust control approach for batch crystallization product design
Nagy, Z. K. (2009) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2009.04.012 · Cited by 191
The role of nanopore shape in surface-induced crystallization
Diao, Y., Harada, T., Myerson, A. S., Alan Hatton, T., & Trout, B. L. (2011) · Nature Materials · doi:10.1038/nmat3117 · Cited by 184
Engineering Crystal Morphology
Dandekar, P., Kuvadia, Z. B., & Doherty, M. F. (2013) · Annual Review of Materials Research · doi:10.1146/annurev-matsci-071312-121623 · Cited by 163
Gel-Induced Selective Crystallization of Polymorphs
Diao, Y., Whaley, K. E., Helgeson, M. E., Woldeyes, M. A., Doyle, P. S., Myerson, A. S., Hatton, T. A., & Trout, B. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja210006t · Cited by 157
Ultrasound Assisted Crystallization of Paracetamol: Crystal Size Distribution and Polymorph Control
Bhangu, S. K., Ashokkumar, M., & Lee, J. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.5b01470 · Cited by 147
Trends in process analytical technology
Chew, W., & Sharratt, P. (2010) · Analytical Methods · doi:10.1039/c0ay00257g · Cited by 131
Improving the Solubility and Bioavailability of Apixaban via Apixaban–Oxalic Acid Cocrystal
Chen, Y., Li, L., Yao, J., Ma, Y., Chen, J., & Lu, T. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b00266 · Cited by 131
Improving Solubility and Pharmacokinetics of Meloxicam via Multiple-Component Crystal Formation
Weyna, D. R., Cheney, M. L., Shan, N., Hanna, M., Zaworotko, M. J., Sava, V., Song, S., & Sanchez‐Ramos, J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300169c · Cited by 128
Myerson, A. S., Krumme, M., Nasr, M. M., Thomas, H., & Braatz, R. D. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24311 · Cited by 116
Enantioselective inhibition of TNF-? release by thalidomide and thalidomide-analogues
Wnendt, S., Finkam, M., Winter, W., Ossig, J., Raabe, G., & Zwingenberger, K. (1996) · Chirality · doi:10.1002/(sici)1520-636x(1996)8:5<390::aid-chir6>3.0.co;2-i · Cited by 94
Simone, E., Saleemi, A. N., & Nagy, Z. K. (2014) · Organic Process Research & Development · doi:10.1021/op5000122 · Cited by 75
Problems, potentials and future of industrial crystallization
Ulrich, J. G., & Frohberg, P. (2013) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-013-1304-y · Cited by 71
On the Formation of Droperidol Solvates: Characterization of Structure and Properties
Be̅rziņš, A., Skarbulis, E., Rekis, T., & Actiņš, A. (2014) · Crystal Growth & Design · doi:10.1021/cg5003447 · Cited by 71
Jiang, X., Lu, D., Xiao, W., Ruan, X., Fang, J., & He, G. (2015) · AIChE Journal · doi:10.1002/aic.15069 · Cited by 62
Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins
Wang, J., Yu, Q., Dai, W., & Mei, X. (2016) · Chemical Communications · doi:10.1039/c5cc10297a · Cited by 61
Self-citationManipulating Crystallization with Molecular Additives
Shtukenberg, A. G., Lee, S. S., Kahr, B. E., & Ward, M. D. (2014) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061312-103308 · Cited by 59
Crystallization of an active pharmaceutical ingredient that oils out
Lü, J., Li, Y., Wang, J., Ren, G., Rohani, S., & Ching, C. (2012) · Separation and Purification Technology · doi:10.1016/j.seppur.2012.05.015 · Cited by 53
Self-citationSpherulitic Crystallization of L -Tryptophan: Characterization, Growth Kinetics, and Mechanism
Yang, J., Wang, Y., Hao, H., Xie, C., Bao, Y., Yin, Q., Gong, J., Jiang, C., Hou, B., & Wang, Z. (2015) · Crystal Growth & Design · doi:10.1021/acs.cgd.5b01089 · Cited by 44
Self-citationCrystal nucleation in a droplet based microfluidic crystallizer
Teychené, S., & Biscans, B. (2012) · Chemical Engineering Science · doi:10.1016/j.ces.2012.01.036 · Cited by 42
Prohotsky, D. L., & Zhao, F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22735 · Cited by 39
Lin, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.001 · Cited by 35
Brown, C. J., & Ni, X. (2011) · Crystal Growth & Design · doi:10.1021/cg200560b · Cited by 34
Arnaout, T. E., Cullen, P. J., & Sullivan, C. (2016) · Chemical Engineering Science · doi:10.1016/j.ces.2016.04.025 · Cited by 34
Influence of History of Solution in Crystal Nucleation of Fenoxycarb: Kinetics and Mechanisms
Kuhs, M., Żegliński, J., & Rasmuson, Å. C. (2014) · Crystal Growth & Design · doi:10.1021/cg4007795 · Cited by 29
Modeling and Optimal Control of Solution Mediated Polymorphic Transformation of l -Glutamic Acid
Sheikholeslamzadeh, E., & Rohani, S. (2013) · Industrial & Engineering Chemistry Research · doi:10.1021/ie302683u · Cited by 27
Self-citationSunflower protein precipitation in a tubular precipitator
Raphael, M., & Rohani, S. (1999) · The Canadian Journal of Chemical Engineering · doi:10.1002/cjce.5450770315 · Cited by 18
Self-citation
Cited by
Wu, K.-J., Tse, E. C. M., Shang, C., & Guo, Z. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2021.100821 · Cited by 400
Padrela, L., Rodrigues, M. A., Duarte, A., Dias, A. M. A., Braga, M. E. M., & de Sousa, H. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.010 · Cited by 262
Metadata
- Authors
- Gao, Z., Rohani, S., Gong, J., & Wang, J.
- Venue
- Engineering
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 3
- Issue
- 3
- Pages
- 343-353
- ISSN
- 2095-8099 (ISSN-L)
- OpenAlex
- W2733077120
- Cited by
- 260
- References
- 53
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.